Note: Ingredients listed on restricted chemical lists
EC/CAS
57-15-8
Name of the chemical
Chlorobutanol
Concentration
0.5 %
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2015-10-06
Product name
Oxytocin Injection, USP
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
DANGER
Section 2
Signal word
DANGER. GHS Class: Respiratory sensitisation. Category 1. Skin Sensitization. Category 1.
Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction.
Precautionary statements
Avoid breathing dust/fume/gas/mist/vapours/spray. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection. In case of inadequate ventilation wear respiratory protection. IF ON SKIN: Wash with plenty of water. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Specific treatment (see ... on this label). If skin irritation or rash occurs: Get medical advice/attention. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Take off contaminated clothing and wash it before reuse. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview: This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation, Ingestion, Eye contact, Skin Absorption., Injection.
Potential health effects
Eye: Contact with eyes may cause irritation. Skin: May cause skin irritation. Inhalation: May cause irritation of respiratory tract. Ingestion: May cause irritation. Signs/Symptoms: Potential adverse reactions from prescribed doses and overdoses are described in the package insert. Possible adverse reactions that have been reported in the mother include: anaphylactic reaction, postpartum hemorrhage, cardiac arrhythmia, fatal afibrinogenemia, nausea, vomiting, premature ventricular contractions, and pelvic hematoma. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with a history of hypersensitivity reaction to oxytocin. Oxytocin stimulates uterine Conditions: contractions similar to those seen in normal labor.